Back to Search
Start Over
Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice.
- Source :
-
Scandinavian Journal of Immunology . Feb2016, Vol. 83 Issue 2, p102-108. 7p. - Publication Year :
- 2016
-
Abstract
- Anti-inflammation strategy is one of the proposed therapeutic approaches to hepatic fibrosis. IL-17 is critical in inflammation, but the role of IL-17 in liver fibrosis has not yet been elucidated. In this study, we investigate the role of IL-17 on bile duct ligation-induced liver injury and fibrosis in C57BL/6 mice. Animals were sacrificed at designated times, and serum and liver tissues were collected for analysis of liver function and serum IL-6, IL-1β, tumour necrosis factor-alpha ( TNF-α) and transforming growth factor-β ( TGF-β) levels. IL-17 blockade with anti- IL-17A mAb significantly improved liver function and decreased hepatocellular necrosis, pro-inflammatory cytokines, neutrophils and macrophages influx. Furthermore, CD3 + and CD8 + lymphocytes, neutrophils and macrophages were found to express IL-17, and neutrophils are the principal IL-17-producing cells after BDL-induced liver injury. These data indicated that IL-17 signal contributes to the pathogenesis of cholestatic liver injury and blocked of IL-17 could potentially benefit patients with cholestatic liver disease. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03009475
- Volume :
- 83
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Scandinavian Journal of Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 112534881
- Full Text :
- https://doi.org/10.1111/sji.12395